CSPC Pharmaceutical Group Limited
CSPCY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $53,797,993 | $85,516,178 | $94,923,283 | $100,176,524 |
| - Cash | $6,777,199 | $12,015,223 | $11,654,606 | $9,283,642 |
| + Debt | $507,330 | $706,901 | $621,479 | $102,760 |
| Enterprise Value | $47,528,124 | $74,207,856 | $83,890,156 | $90,995,642 |
| Revenue | $30,867,889 | $34,599,374 | $35,012,349 | $34,188,155 |
| % Growth | -10.8% | -1.2% | 2.4% | – |
| Gross Profit | $21,599,258 | $24,397,354 | $22,726,458 | $25,472,247 |
| % Margin | 70% | 70.5% | 64.9% | 74.5% |
| EBITDA | $6,864,511 | $8,532,758 | $8,655,091 | $9,275,387 |
| % Margin | 22.2% | 24.7% | 24.7% | 27.1% |
| Net Income | $4,605,334 | $5,873,325 | $6,893,834 | $6,876,658 |
| % Margin | 14.9% | 17% | 19.7% | 20.1% |
| EPS Diluted | 1.56 | 2 | 2.04 | 1.88 |
| % Growth | -22% | -2% | 8.5% | – |
| Operating Cash Flow | $4,534,664 | $4,178,815 | $7,627,064 | $4,636,627 |
| Capital Expenditures | -$2,678,876 | -$1,893,067 | -$2,722,692 | -$1,758,448 |
| Free Cash Flow | $1,855,788 | $2,285,748 | $4,904,372 | $2,878,179 |